290 related articles for article (PubMed ID: 25542054)
1. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
Asensio Á; Cantero M; Shaw E; Vergara-López S
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():61-6. PubMed ID: 25542054
[TBL] [Abstract][Full Text] [Related]
2. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
Oteo J; Miró E; Pérez-Vázquez M; Navarro F
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
[TBL] [Abstract][Full Text] [Related]
3. Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.
Paño Pardo JR; Serrano Villar S; Ramos Ramos JC; Pintado V
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():41-8. PubMed ID: 25542051
[TBL] [Abstract][Full Text] [Related]
4. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?
Pascual Á; Pintado V; Rodríguez-Baño J; Miró JM
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of infections caused by carbapenemase-producing Enterobacteriaceae: reservoirs and transmission mechanisms.
López-Cerero L; Almirante B
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():10-6. PubMed ID: 25542047
[TBL] [Abstract][Full Text] [Related]
6. Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.
Rodríguez-Baño J; Cisneros JM; Gudiol C; Martínez JA
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():49-55. PubMed ID: 25542052
[TBL] [Abstract][Full Text] [Related]
7. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Goodman KE; Simner PJ; Tamma PD; Milstone AM
Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
[TBL] [Abstract][Full Text] [Related]
8. Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings.
Bou G; Vila J; Seral C; Castillo FJ
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():24-32. PubMed ID: 25542049
[TBL] [Abstract][Full Text] [Related]
9. Carbapenemase-producing Enterobacteriaceae: a call for action!
Nordmann P; Cornaglia G
Clin Microbiol Infect; 2012 May; 18(5):411-2. PubMed ID: 22507108
[No Abstract] [Full Text] [Related]
10. Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.
Mataseje LF; Abdesselam K; Vachon J; Mitchel R; Bryce E; Roscoe D; Boyd DA; Embree J; Katz K; Kibsey P; Simor AE; Taylor G; Turgeon N; Langley J; Gravel D; Amaratunga K; Mulvey MR
Antimicrob Agents Chemother; 2016 Nov; 60(11):6787-6794. PubMed ID: 27600052
[TBL] [Abstract][Full Text] [Related]
11. Future alternatives for the treatment of infections caused by carbapenemase-producing Enterobacteriaceae: what is in the pipeline?
Horcajada JP; Torre-Cisneros J; Peña C; Fariñas MC
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():56-60. PubMed ID: 25542053
[TBL] [Abstract][Full Text] [Related]
12. Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved?
Cantón R; Canut A; Morosini MI; Oliver A
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():33-40. PubMed ID: 25542050
[TBL] [Abstract][Full Text] [Related]
13. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):256-60. PubMed ID: 19300408
[TBL] [Abstract][Full Text] [Related]
14. Control of an outbreak due to orthopedic infections caused by Enterobacteriaceae producing IMP-4 or IMP-8 carbapenemases.
Pang F; Jia XQ; Wang B; Li YH; Zhao QG
Pathol Biol (Paris); 2014 Jun; 62(3):152-5. PubMed ID: 24685523
[TBL] [Abstract][Full Text] [Related]
15. [KPC carbapenemases: what is at stake in clinical microbiology?].
Cuzon G; Naas T; Nordmann P
Pathol Biol (Paris); 2010 Feb; 58(1):39-45. PubMed ID: 19854586
[TBL] [Abstract][Full Text] [Related]
16. Carbapenemase-producing enterobacteriaceae (CPE) in the pediatric setting: results from an 18-month survey.
Colombo S; Scolfaro C; Calitri C; Denina M; Carraro F; De Intinis G; Tovo PA
Infect Control Hosp Epidemiol; 2014 May; 35(5):599-601. PubMed ID: 24709738
[No Abstract] [Full Text] [Related]
17. Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review.
French CE; Coope C; Conway L; Higgins JP; McCulloch J; Okoli G; Patel BC; Oliver I
J Hosp Infect; 2017 Jan; 95(1):3-45. PubMed ID: 27890334
[TBL] [Abstract][Full Text] [Related]
18. A single-day point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae.
Ruiz-Garbajosa P; Hernández-García M; Beatobe L; Tato M; Méndez MI; Grandal M; Aranzábal L; Alonso S; Lópaz MÁ; Astray J; Cantón R
J Antimicrob Chemother; 2016 Feb; 71(2):348-52. PubMed ID: 26518051
[TBL] [Abstract][Full Text] [Related]
19. Carbapenemase-producing Enterobacteriaceae: use of a dynamic registry of cases and contacts for outbreak management.
Clarivet B; Pantel A; Morvan M; Jean Pierre H; Parer S; Jumas-Bilak E; Lotthé A
J Hosp Infect; 2016 Jan; 92(1):73-7. PubMed ID: 26542949
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a statewide network for carbapenem-resistant enterobacteriaceae prevention in a low-incidence region.
Pfeiffer CD; Cunningham MC; Poissant T; Furuno JP; Townes JM; Leitz A; Thomas A; Buser GL; Arao RF; Beldavs ZG
Infect Control Hosp Epidemiol; 2014 Apr; 35(4):356-61. PubMed ID: 24602939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
